IRVINE, Calif.--(BUSINESS WIRE)--
Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative
treatments for aortic disorders, today announced that John McDermott,
Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer,
will present at the 36th Annual J.P. Morgan Healthcare
Conference at 1:30 p.m. PT on Monday, January 8, 2018 in San Francisco,
A live webcast of the presentation and Q&A breakout session will be
accessible through the "Investors" section of the Company's website at www.endologix.com
and will be available for replay following the event.
About Endologix, Inc.
Endologix, Inc. develops and
manufactures minimally invasive treatments for aortic disorders. The
Company's focus is endovascular stent grafts for the treatment of
abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the
aorta, the largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if left
untreated, becomes increasingly susceptible to rupture. The overall
patient mortality rate for ruptured AAA is approximately 80%, making it
a leading cause of death in the United States. For more information,
View source version on businesswire.com: http://www.businesswire.com/news/home/20171219005934/en/
Source: Endologix, Inc.
News Provided by Acquire Media